A program to help middle school students improve their health through civic engagement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Strong Teens for Healthy Schools program is a school-based initiative aimed at empowering middle school students to enhance their physical activity and healthy eating habits. This cluster-randomized controlled trial will involve Title 1 middle schools in Texas, where schools will be randomly assigned to either the intervention group, which participates in the STHS program, or a control group that continues with usual care. The program focuses on creating positive changes in school health environments and aims to improve cardiovascular disease-related outcomes among 6th and 7th-grade students. The effectiveness of the program will be evaluated immediately after the intervention and one year later.

Why it matters

Who can join: the full rules

School Inclusion Criteria:

* \> 50 6th and 7th grade students
* \> 40% economically disadvantaged students
* \> 40% Black and Hispanic students

School Exclusion Criteria:

Student Inclusion Criteria:

* 6th or 7th grade student
* Attend a Title 1 middle school that is participating in the STHS intervention
* Read and understand English

Student Exclusion Criteria:

* Participation in a weight loss program in the past 3 months
* Presence of a condition that prevents participation in physical activity

Where it's running

• Texas A&M AgriLife Dallas Center
  Dallas, Texas, United States Recruiting

Study contacts

• Study coordinator: Jacob S Szeszulski, PhD
• Email: jacob.szeszulski@ag.tamu.edu
• Phone: 972-231-5362

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.